Atlas Trials

Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis

Clinical trial NCT07411963 · RECRUITING

Trial details

NCT number
NCT07411963
Sponsor
Centre Hospitalier Universitaire de Nice
Status
RECRUITING
Study type
OBSERVATIONAL
Myasthenia Gravis
Start date
2025-11-26
Primary completion
2026-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.